Joel Gelfand of the Perelman School of Medicine comments on psoriasis analyses.
Perelman School of Medicine
Arthur Caplan of the Perelman School of Medicine is interviewed about the growth in foreign drug testing.
Lance Becker of the Perelman School of Medicine is quoted about the use of therapeutic hypothermia.
Jason Burdick of the School of Engineering and Applied Science and Robert Mauck of the Perelman School of Medicine discuss their efforts to regrow cartilage that might lead to better treatments.
Medical, Surgical Treatments Equally Effective for Common Inflammatory Eye Condition, Penn Study Finds
PHILADELPHIA — Patients with uveitis, the fifth leading cause of vision loss in the United States, treated with either systemic anti-inflammatory medicine or with a time-release implant surgically placed inside the eye experienced a similar degree of visual improvement over two years, according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania, the Mount Sinai School of Medicine, Johns Hopkins University and the University of Wisconsin.
PHILADELPHIA — University of Pennsylvania Health System (UPHS) is partnering with the Leonard Davis Institute Center for Health Incentives and Behavioral Economics of the University of Pennsylvania on a new initiative to be called the UPHS Center for Innovations in Health Care Financing.
PHILADELPHIA — A $10 million grant from the National Cancer Institute will fund a new center at the Perelman School of Medicine at the University of Pennsylvania focusing on the relationship between exercise, weight loss, and improving the length and quality of life for the nation's 12 million cancer survivors.
Projects in the Penn Transdisciplinary Research on Energetics and Cancer (TREC) Survivor Center will include: